Skip to main content

Advertisement

Log in

The Efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following Carboplatin and Paclitaxel combination chemotherapy for non-small cell lung cancer

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Introduction

To assess the efficacy of Shakuyaku-Kanzo-to, a Japanese herbal medicine, for prophylaxis against paclitaxel-induced myalgia and arthralgia, a comparative study was conducted with 50 patients treated with carboplatin and paclitaxel.

Patients and Methods

Patients were alternatively assigned to receive either the intervention group (with Shakuyaku-Kanzo-to) or the control group (without Shakuyaku-Kanzo-to). We assessed the grade and the duration of myalgia and arthralgia.

Results

The grades of myalgia and arthralgia in the control group were significantly higher than the grades determined in the intervention group (p = 0.018). The mean duration of myalgia and arthralgia was 2.78 ± 2.09 days for the intervention group and 5.08 ± 2.89 days for the control group. The duration was significantly shorter in the intervention group than in the control group (p = 0.002).

Discussion

This study shows that prophylactic administration of Shakuyaku-Kanzo-to was effective against paclitaxel-induced myalgia and arthralgia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Boyle FM, Monk R, Davey R et al (1996) Prevention of experimental paclitaxel neuropathy with glutamate. Proc AACR 37(Abstr #1974):290

    Google Scholar 

  2. Brystol-Myers Squibb (1996) Taxol (paclitaxel) injection prescribing information. Brystol-Myers Squibb, Princeton, pp 1–6

    Google Scholar 

  3. Fujii K, Okamoto S, Saitoh K, Sasaki N, Takano M, Tanaka S (2004) The efficacy of Shakuyaku-Kanzo-to for peripheral nerve dysfunction in paclitaxel combination chemotherapy for epithelial ovarian carcinoma. Gan To Kagaku Ryoho 31(10):1537–1540

    PubMed  Google Scholar 

  4. Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M et al (2004) Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer. JCO 2004:3852–3859

    Article  Google Scholar 

  5. Moriyama T, Higashi T, Yogashi K, Iida T, Segi E, Sugimoto Y et al (2005) Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol Pain 1(1):3. doi:10.1186/1744-8069-1-3

    Article  PubMed  Google Scholar 

  6. Murata T, Ushikabi F, Matsuoka T, Hirata M, Yamasaki A, Sugimoto Y et al (1997) Alterd pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388:678–682. doi:10.1038/41780

    Article  PubMed  CAS  Google Scholar 

  7. Non-small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311:899–909

    Google Scholar 

  8. Oho Y, Ohashi Y, Kubota K et al (2007) Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small cell lung cancer: Four-Arm Cooperative Study in Japan. Ann Oncol 18(2):317–323. doi:10.1093/annonc/mdl377

    Article  Google Scholar 

  9. Ohuchi K, Kamada Y, Levine L, Tsurufuji S (1981) Glycyrrhizin inhibits prostaglandin E2 production by activated peritoneal macrophages from rats. Prostaglandins Med 7(5):457–463. doi:10.1016/0161-4630(81)90033-1

    Article  PubMed  CAS  Google Scholar 

  10. Rowinsky EK, Donehower RC, Jones RJ, Tucker RW (1988) Microtubule changes and cytotoxicity in leukemic cell line treated with Taxol. Cancer Res 48:4093–4100

    PubMed  CAS  Google Scholar 

  11. Samad TA, Sapirstein A, Woolf CJ (2002) Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets. Trends Mol Med 8:390–396. doi:10.1016/S1471-4914(02)02383-3

    Article  PubMed  CAS  Google Scholar 

  12. Schiff PB, Horwitz SB (1981) Taxol assembles tubulin in the absence of exogenous guanosine 5’-triphosphate or microtubule-associated proteins. Biochemistry 20:3247–3252. doi:10.1021/bi00514a041

    Article  PubMed  CAS  Google Scholar 

  13. Shiki Y, Ishihara Y, Shirai K, Saito Y, Yoshida S (1986) Effect of glycyrrhizin on lysosomes labilization by phospholipase A2. Am J Chin Med 14:131–137. doi:10.1142/S0192415X86000211

    Article  PubMed  CAS  Google Scholar 

  14. Van Deventer H, Bernard S (1999) Use of gabapentin to treat taxan-induced myalgia. J Clin Oncol 17(1):434–435

    PubMed  Google Scholar 

  15. Yana T, Takada M, Origasa H, Ijima T, Yamamoto N, Nakagawa K (2002) New chemotherapy agent plus platinum for advanced non-small cell lung cancer: a meta-analysis. Proc Am Soc Clin Oncol 21:328a

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tsutomu Yoshida.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoshida, T., Sawa, T., Ishiguro, T. et al. The Efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following Carboplatin and Paclitaxel combination chemotherapy for non-small cell lung cancer. Support Care Cancer 17, 315–320 (2009). https://doi.org/10.1007/s00520-008-0508-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-008-0508-z

Keywords

Navigation